Simultaneous quantification of first-line anti-tuberculosis drugs and metabolites in human plasma
Tuberculosis (TB) currently kills more people than any other infectious disease worldwide, the highest burden being in Africa and Asia (1). Therapy recommended for drug sensitive TB consists of a cocktail of isoniazid (INH), rifampicin (RIF), pyrazinamide (PZA) and ethambutol (EMB), all given in a 2...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Dissertation |
| Language: | English |
| Published: |
Faculty of Health Sciences
2020
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/11427/31100 |